
Is multi-attribute monitoring ready for QC? Insights from an interlaboratory study
During the 8th Bioproduction Congress organised by MabDesign, Arnaud Delobel presented the latest insi
During the 8th Bioproduction Congress organised by MabDesign, Arnaud Delobel presented the latest insi
During the conference "Challenges and Opportunities in Biotherapeutics Analytics", Damien Mouvet presented on the physico-chemical characterisation of rAAV. Download the slides to explore the topics and case studies he presented:
During Waters Biopharma Seminar Day, Thomas Menneteau, R&D Scientist, presented on the Multiple Attribute Monitoring of therapeutic mRNA.
In this presentation, held during the 14th Multidimensional Chromatography Working, Arnaud Delobel covered the following topics:
During Waters European Biopharma Analytical Forum 2022 (Webaf), Claire Butré presented on Multiple-Attribute Monitoring in QC.
During her talk, she covered the following topics:
In this presentation, Géry Van Vyncht covered the following topics:
Discover more about the use of Octet in a GMP regulated environment.
During this presentation, Arnaud Delobel goes through different subjects:
Discover more about the applications of the 2D-LC/MS at Quality Assistance and how advances in analytical characterisation of mAbs can help you speed up time to market of your biotherapeutics
In this presentation, Arnaud Delobel explains how the development of liquid chromatography (LC) methods has long been done using a trial-and-error approach, also known as “one factor at a time” (OFAT).
ICP-MS/MS: An Innovative Approach for the Characterisation of Therapeutic Oligonucleotides
ICP-MS/MS methodologies were developed for the characterisation of therapeutic oligonucleotides:
Quality Assistance developed an innovative method for the absolute quantification of therapeutic oligonucleotides, as well as for the determination of phosphodiester-to-phosphorothioate (PO/PS) ratio by ICP-MS.MS.
Discover more about our applications of 2D-LC/MS at Quality Assistance and how those systems can be used in regulated environments for the characterisation of biotherapeutics.